Empower Advisory Group
GSK icon

Empower Advisory Group’s GSK GSK Stock Holding History

Empower Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,630
Closed -$277K – 477
2023
Q3 		$277K Buy
+7,630
New +$271K ﹤0.01% 398
2023
Q2 		– Sell
-6,790
Closed -$244K – 490
2023
Q1 		$244K Buy
+6,790
New +$238K ﹤0.01% 434

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Empower Advisory Group's GSK Position: Q4 2023 in Review

Empower Advisory Group sold out of GSK (GSK) in Q4 2023, closing a stake of 7,630 shares — an estimated $277K sold.

Empower Advisory Group first reported a position in GSK in Q1 2023 and held it in 2 quarters. The position peaked at $277K in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Empower Advisory Group reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
  • Empower Advisory Group sold 7,630 GSK shares in Q4 2023, an estimated $277K.
  • Empower Advisory Group first reported a position in GSK in Q1 2023 and held it in 2 quarters.
  • Empower Advisory Group's GSK position peaked at $277K in Q3 2023.
  • 895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Empower Advisory Group's 13F filing for Q4 2023, filed 7 Feb 2024.